Cargando…
Patient–reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia
Acute myeloid leukemia (AML) is associated with poor survival. While clinical prognostic factors of survival have been identified, the contribution of patient-reported symptoms has only received marginal attention. Fatigue is one of the most commonly reported symptoms of AML. There is some evidence...
Autores principales: | Lacourt, Tamara E., Kavelaars, Annemieke, Ohanian, Maro, Shah, Nina D., Shelburne, Samuel A., Futreal, Andrew, Kontoyiannis, Dimitrios P., Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101294/ https://www.ncbi.nlm.nih.gov/pubmed/30131851 http://dx.doi.org/10.18632/oncotarget.25787 |
Ejemplares similares
-
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016) -
Mechanisms of chemotherapy-induced behavioral toxicities
por: Vichaya, Elisabeth G., et al.
Publicado: (2015) -
IL-1β reactivity and the development of severe fatigue after military deployment: a longitudinal study
por: van Zuiden, Mirjam, et al.
Publicado: (2012) -
Tumour necrosis factor-α stimulates dehydroepiandrosterone metabolism in human fibroblast-like synoviocytes: a role for nuclear factor-κB and activator protein-1 in the regulation of expression of cytochrome p450 enzyme 7b
por: Dulos, John, et al.
Publicado: (2005) -
Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin
por: Boukelmoune, Nabila, et al.
Publicado: (2018)